What Makes a Medication Prescription Only

Answer first: two doors lead into the category

A prescription requirement feels like a fact about a substance. It is closer to a classification, and the statute that creates it names exactly two ways a drug ends up inside.

The first is a safety judgment about the drug itself. A drug for human use falls into the category on a stated ground. The ground is its toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use. The test is whether, on one of those grounds, the drug is not safe for use except under the supervision of a practitioner licensed by law to administer it.

The second is administrative. A drug is also in the category if it is limited by an approved application to use under the professional supervision of such a practitioner.

Those two limbs do different work. The first describes a hazard. The second describes a decision recorded in a marketing application, which is the ordinary route for a modern product.

The three grounds inside the first limb

The first limb is often summarized as toxicity, and it is wider than that. It names three separate grounds, joined by the word or.

Toxicity or other potentiality for harmful effect is only the first. The method of its use is the second, and it points at how a product is taken rather than at what it contains.

The third is the one most people have never read. Collateral measures necessary to its use is a phrase about everything that has to happen around a medication for it to be used safely.

That third ground is the reason a substance can require supervision even where the substance itself is not the difficult part. What surrounds it can be.

The symbol runs in both directions

The category has a mark, and the statute treats the mark as load-bearing rather than decorative. The familiar half of the rule is that a drug in the category is misbranded if its label fails to bear the symbol before dispensing.

The half nobody quotes is the mirror. A drug to which the prescription paragraph does not apply is misbranded if, at any time before dispensing, its label bears that symbol.

So the mark is not a claim a company may make about itself for reassurance. Printing it on a product outside the category is a labeling defect in its own right.

That symmetry is worth carrying into any page where the mark appears as a trust signal. It reports a classification. It reports nothing about approval, effectiveness or quality.

There is a written way out, and a person can start it

The same subsection contains an exit. The Secretary may by regulation remove drugs subject to the approval section from the prescription requirement when those requirements are not necessary for the protection of the public health.

A regulation fills in how that happens, and it is titled the prescription-exemption procedure. It opens by saying that a drug limited to prescription use under the application-limited limb remains so limited until it is exempted under the procedure.

The test has two findings, and both must be made. The Commissioner has to find that the prescription-dispensing requirements are not necessary for the protection of the public health. That finding is made by reason of the drug's toxicity or other potentiality for harmful effect, or the method of its use, or the collateral measures necessary to its use.

The second finding is the harder one. The Commissioner has to find that the drug is safe and effective for use in self-medication as directed in proposed labeling.

Who may start it is the surprising part. A proposal may be initiated by the Commissioner or by any interested person, and any interested person may file a petition seeking the exemption. The petition may run through the agency's general petition procedures or arrive as a supplement to an approved application.

Two consequences that follow an exemption

Coming out of the category does not immediately make a product an ordinary shelf item. The regulation says a drug exempted under the procedure is still a new drug within the meaning of the act. That status lasts until it has been used to a material extent and for a material time under the exempted conditions.

The second consequence closes the loop on the symbol. Using the prescription caution statement in the labeling of a drug exempted under the procedure constitutes misbranding.

The regulation then extends that in softer language. Any other statement or suggestion in the labeling of an exempted drug that the drug is limited to prescription use may constitute misbranding.

Read together, the two paragraphs say the classification and its mark move as a unit. A product cannot be out of the category and still wear it.

A second route, aimed at ingredients rather than products

The exemption procedure names one alternative. A drug limited to prescription use under the application-limited limb may also be exempted by the procedure set out in a separate section, which sits inside the agency's rules for over-the-counter drug monographs.

That section works on active ingredients and their conditions of use rather than on one company's product. It addresses when an ingredient limited to prescription use, and not thereafter exempted under the prescription-exemption procedure, is regarded as a new drug requiring an approved application.

The distinction matters for reading a claim. One route changes the status of a product with an application behind it. The other operates on the ingredient in a class of products.

Both are procedures with published tests. Neither is a marketing decision a company announces on its own.

Why this shows up in a list of labeling changes

A separate regulation defines the instrument used to change what an approved label says, and its definition carries an eight-item list of the changes that instrument covers.

One of those eight items is changing marketing status from prescription to over-the-counter use. It sits between altering the intended patient population and providing for traditional approval of a product first approved under an accelerated pathway.

A reader meeting the item there gets the change named and never told what the status is. The test above is what the item is referring to, and the two documents belong side by side.

The corpus already carries the labeling-change list. It has never carried the status the list is talking about.

What the classification does downstream

Prescription status is not only a rule about who may hand a product over. Other rules borrow the classification and attach their own duties to it.

One example is the special-packaging rule. It reaches a drug in a dosage form intended for oral administration. The second half of its trigger is that the drug is required by federal law to be dispensed only by or upon an oral or written prescription of a licensed practitioner. The trigger is the classification, quoted almost word for word.

Another is the labeling exemption that lets a prescription drug package carry professional information rather than full directions for a consumer. That exemption is available to a drug subject to the prescription requirement, on stated conditions.

So the category is a hinge. Answering whether a product is in it settles several questions at once, which is why the entry test is worth reading rather than assuming.

What this settles, and what it does not

It settles what the requirement is. Prescription status is a classification created by a two-limb test in a statute. It is marked by a symbol that is required inside the category and prohibited outside it. It is removable only by a published procedure with two findings.

It settles who can raise the question. Any interested person may petition, which is unusual among the procedures this site describes.

It does not settle anything about any particular medication's future. Nothing here says which products have been through the procedure, which might, or on what timetable, and a page that reads a mechanism as a forecast has added something the documents do not contain.

And it does not touch clinical questions. Whether a specific product suits a specific person is a conversation with a prescriber and a pharmacist, and no classification answers it.